Voyager Therapeutics, Inc. Common Stock

$3.500
USD
Last updated on --.
24h volume540.80K
24h highest3.5950 USD
24h lowest3.4300 USD
24h Price movement+1.16%

VYGR recent prices

24 Hours
+1.16%+$0.04
30 days
-15.68%-$0.665
60 days
-9.26%-$0.365
90 days
-17.25%-$0.745

Key data

Previous close3.4600 USD
Market cap201.20M USD
Volume540.80K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.9400 USD
Net income (FY)-116.64M USD
Revenue (FY)36.49M USD
Last report dateMay 7, 2026

About Voyager Therapeutics, Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
HeadquartersLEXINGTON
Employees (FY)141.00
Revenue per employee (FY)258.82K USD
Net income per employee (FY)-827.21K USD
Listed onNasdaq
Official website

VYGR conversion tables

VYGRVYGR
USDUSD
0.5 VYGR1.750 USD
1 VYGR3.500 USD
5 VYGR17.5 USD
10 VYGR35 USD
USDUSD
VYGRVYGR
0.5 USD0.14286 VYGR
1 USD0.28571 VYGR
5 USD1.428 VYGR
10 USD2.857 VYGR

FAQ

VYGR is trading at $3.500, +1.16% over the last 24 hours. Track live moves on the price chart at the top of this page.
The VYGR stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. VYGR is currently trading at $3.500, +1.16% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on VYGR price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. VYGR's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from VYGR; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against VYGR's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Voyager Therapeutics, Inc. Common Stock's market cap is currently 201.20M USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume540.80K
24h highest3.5950 USD
24h lowest3.4300 USD
24h Price movement+1.16%
VYGRVYGR
USDUSD
Start trade with VYGR Perpetual